Radiosurgery for angiographically occult vascular malformations.

Martin Pham, Bradley A. Gross, Bernard R. Bendok, Issam A. Awad, H. Hunt Batjer

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The use of radiosurgery for angiographically occult vascular malformations (AOVMs) is a controversial treatment option for those that are surgically inaccessible or located in eloquent brain. To determine the efficacy of this treatment, the authors reviewed the literature reporting hemorrhage rates, seizure control, and radiation-induced morbidity. They found overall hemorrhage rates of 2-6.4%, overall postradiosurgery hemorrhage rates of 1.6-8%, and stratified postradiosurgery hemorrhage rates of 7.3-22.4% in the period immediately to 2 years after treatment; these latter rates declined to 0.8-5.2% > 2 years after treatment. Of 291 patients presenting with seizure across 16 studies, 89 (31%) attained a seizure-free status and 102 (35%) had a reduction in seizure frequency after radiosurgery. Overall radiation-induced morbidity ranged from 2.5 to 59%, with higher complication rates in patients with brainstem lesion locations. Researchers applying mean radiation doses of 15-16.2 Gy to the tumor margin saw both low radiation-induced complication rates (0-9.1%) and adequate hemorrhage control (0.8-5.2% > 2 years after treatment), whereas mean doses >or= 16.5 Gy were associated with higher total radiation-induced morbidity rates (> 17%). Although the use of stereotactic radiosurgery remains controversial, patients with AOVMs located in surgically inaccessible areas of the brain may benefit from such treatment.

Original languageEnglish (US)
JournalNeurosurgical Focus
Volume26
Issue number5
DOIs
StatePublished - May 2009

Fingerprint

Vascular Malformations
Radiosurgery
Radiation
Hemorrhage
Seizures
Morbidity
Therapeutics
Brain
Brain Stem
Research Personnel
Neoplasms

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Radiosurgery for angiographically occult vascular malformations. / Pham, Martin; Gross, Bradley A.; Bendok, Bernard R.; Awad, Issam A.; Batjer, H. Hunt.

In: Neurosurgical Focus, Vol. 26, No. 5, 05.2009.

Research output: Contribution to journalArticle

Pham, Martin ; Gross, Bradley A. ; Bendok, Bernard R. ; Awad, Issam A. ; Batjer, H. Hunt. / Radiosurgery for angiographically occult vascular malformations. In: Neurosurgical Focus. 2009 ; Vol. 26, No. 5.
@article{fb89c21de0d54bff9b283e1b9f360251,
title = "Radiosurgery for angiographically occult vascular malformations.",
abstract = "The use of radiosurgery for angiographically occult vascular malformations (AOVMs) is a controversial treatment option for those that are surgically inaccessible or located in eloquent brain. To determine the efficacy of this treatment, the authors reviewed the literature reporting hemorrhage rates, seizure control, and radiation-induced morbidity. They found overall hemorrhage rates of 2-6.4{\%}, overall postradiosurgery hemorrhage rates of 1.6-8{\%}, and stratified postradiosurgery hemorrhage rates of 7.3-22.4{\%} in the period immediately to 2 years after treatment; these latter rates declined to 0.8-5.2{\%} > 2 years after treatment. Of 291 patients presenting with seizure across 16 studies, 89 (31{\%}) attained a seizure-free status and 102 (35{\%}) had a reduction in seizure frequency after radiosurgery. Overall radiation-induced morbidity ranged from 2.5 to 59{\%}, with higher complication rates in patients with brainstem lesion locations. Researchers applying mean radiation doses of 15-16.2 Gy to the tumor margin saw both low radiation-induced complication rates (0-9.1{\%}) and adequate hemorrhage control (0.8-5.2{\%} > 2 years after treatment), whereas mean doses >or= 16.5 Gy were associated with higher total radiation-induced morbidity rates (> 17{\%}). Although the use of stereotactic radiosurgery remains controversial, patients with AOVMs located in surgically inaccessible areas of the brain may benefit from such treatment.",
author = "Martin Pham and Gross, {Bradley A.} and Bendok, {Bernard R.} and Awad, {Issam A.} and Batjer, {H. Hunt}",
year = "2009",
month = "5",
doi = "10.3171/2009.2.FOCUS0923",
language = "English (US)",
volume = "26",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - Radiosurgery for angiographically occult vascular malformations.

AU - Pham, Martin

AU - Gross, Bradley A.

AU - Bendok, Bernard R.

AU - Awad, Issam A.

AU - Batjer, H. Hunt

PY - 2009/5

Y1 - 2009/5

N2 - The use of radiosurgery for angiographically occult vascular malformations (AOVMs) is a controversial treatment option for those that are surgically inaccessible or located in eloquent brain. To determine the efficacy of this treatment, the authors reviewed the literature reporting hemorrhage rates, seizure control, and radiation-induced morbidity. They found overall hemorrhage rates of 2-6.4%, overall postradiosurgery hemorrhage rates of 1.6-8%, and stratified postradiosurgery hemorrhage rates of 7.3-22.4% in the period immediately to 2 years after treatment; these latter rates declined to 0.8-5.2% > 2 years after treatment. Of 291 patients presenting with seizure across 16 studies, 89 (31%) attained a seizure-free status and 102 (35%) had a reduction in seizure frequency after radiosurgery. Overall radiation-induced morbidity ranged from 2.5 to 59%, with higher complication rates in patients with brainstem lesion locations. Researchers applying mean radiation doses of 15-16.2 Gy to the tumor margin saw both low radiation-induced complication rates (0-9.1%) and adequate hemorrhage control (0.8-5.2% > 2 years after treatment), whereas mean doses >or= 16.5 Gy were associated with higher total radiation-induced morbidity rates (> 17%). Although the use of stereotactic radiosurgery remains controversial, patients with AOVMs located in surgically inaccessible areas of the brain may benefit from such treatment.

AB - The use of radiosurgery for angiographically occult vascular malformations (AOVMs) is a controversial treatment option for those that are surgically inaccessible or located in eloquent brain. To determine the efficacy of this treatment, the authors reviewed the literature reporting hemorrhage rates, seizure control, and radiation-induced morbidity. They found overall hemorrhage rates of 2-6.4%, overall postradiosurgery hemorrhage rates of 1.6-8%, and stratified postradiosurgery hemorrhage rates of 7.3-22.4% in the period immediately to 2 years after treatment; these latter rates declined to 0.8-5.2% > 2 years after treatment. Of 291 patients presenting with seizure across 16 studies, 89 (31%) attained a seizure-free status and 102 (35%) had a reduction in seizure frequency after radiosurgery. Overall radiation-induced morbidity ranged from 2.5 to 59%, with higher complication rates in patients with brainstem lesion locations. Researchers applying mean radiation doses of 15-16.2 Gy to the tumor margin saw both low radiation-induced complication rates (0-9.1%) and adequate hemorrhage control (0.8-5.2% > 2 years after treatment), whereas mean doses >or= 16.5 Gy were associated with higher total radiation-induced morbidity rates (> 17%). Although the use of stereotactic radiosurgery remains controversial, patients with AOVMs located in surgically inaccessible areas of the brain may benefit from such treatment.

UR - http://www.scopus.com/inward/record.url?scp=67651166910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651166910&partnerID=8YFLogxK

U2 - 10.3171/2009.2.FOCUS0923

DO - 10.3171/2009.2.FOCUS0923

M3 - Article

C2 - 19408994

AN - SCOPUS:67651166910

VL - 26

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 5

ER -